Related Experiment Video
Updated: Jun 7, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Per-Patient Illness Trajectory Analyses
Juliet Jacobsen1,2, Karin Boo Hammas3, Mikael Segerlantz1,4,5
1Department of Clinical Sciences Lund, Medical Oncology, Lund University, Lund, Sweden.
Abstract:
Summary statistics often hide individual patients' suffering, thereby impeding quality improvement efforts. We aimed to show the experience of a population with health care toward the end of life while preserving the experience of the individual. We developed a data display method called per-patient illness trajectory analysis. We tested it using a demonstration cohort of 192 patients with cancer referred to a regional Swedish specialized home-based palliative care practice. Chart review provided detailed information about illness trajectory events with a focus on unplanned hospitalization. We created per-patient timelines spanning from cancer diagnosis until death and using a logarithmic scale: Compared with a conventional, linear timescale, this scale expands the time resolution toward the end of life. The method fosters the assessment of unmet palliative care need and care quality for individuals, small high-need groups, and populations. In populations of up to 200 people, per-patient illness trajectory analysis is feasible and promising. Using random sampling, it could be extended to larger populations.
Related Concept Videos
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Interpreting Run Charts
Steps in Outbreak Investigation
Cancer Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

